{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:14:31Z","timestamp":1790777671872,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK090242"],"award-info":[{"award-number":["DK090242"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1CA174713"],"award-info":[{"award-number":["RO1CA174713"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jbc.2021.100283","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T16:00:01Z","timestamp":1610553601000},"page":"100283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Acquired deficiency of peroxisomal dicarboxylic acid catabolism is a metabolic vulnerability in hepatoblastoma"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-3243","authenticated-orcid":false,"given":"Huabo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Schwalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna E.","family":"Gorka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan A.","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9476-309X","authenticated-orcid":false,"given":"Eric S.","family":"Goetzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6214-9167","authenticated-orcid":false,"given":"Sarangarajan","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F.","family":"Dobrowolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward V.","family":"Prochownik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2021.100283_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc.2016.114","article-title":"From Krebs to clinic: Glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2021.100283_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fendo.2018.00129","article-title":"The role for myc in coordinating glycolysis, oxidative phosphorylation, glutaminolysis, and fatty acid metabolism in normal and neoplastic tissues","volume":"9","author":"Goetzman","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jbc.2021.100283_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2021.100283_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41586-020-2124-0","article-title":"Dietary modifications for enhanced cancer therapy","volume":"579","author":"Kanarek","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.100283_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-319-77736-8_2","article-title":"Glutamine metabolism in cancer","volume":"1063","author":"Li","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jbc.2021.100283_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2021.100283_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the Intersections between metabolism and cancer Biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2021.100283_bib8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbabio.2010.08.010","article-title":"The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression","volume":"1807","author":"Diaz-Ruiz","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2021.100283_bib9","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","article-title":"Targeting metabolism for cancer therapy","volume":"24","author":"Luengo","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2021.100283_bib10","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative phosphorylation as an Emerging target in cancer therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2021.100283_bib11","doi-asserted-by":"crossref","first-page":"e10769","DOI":"10.7554\/eLife.10769","article-title":"Mitochondrial DNA copy number variation across human cancers","volume":"5","author":"Reznik","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2021.100283_bib12","doi-asserted-by":"crossref","first-page":"165656","DOI":"10.1016\/j.bbadis.2019.165656","article-title":"c-Myc directly targets an over-expression of pyruvate carboxylase in highly invasive breast cancer","volume":"1866","author":"Lao-On","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.jbc.2021.100283_bib13","doi-asserted-by":"crossref","first-page":"e0129848","DOI":"10.1371\/journal.pone.0129848","article-title":"Pyruvate carboxylase is up-regulated in breast cancer and essential to support growth and Invasion of MDA-MB-231 cells","volume":"10","author":"Phannasil","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.100283_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2174\/1568026618666180523111351","article-title":"Inhibition of glycolysis and glutaminolysis: An Emerging drug discovery approach to Combat cancer","volume":"18","author":"Akins","year":"2018","journal-title":"Curr. Top Med. Chem."},{"key":"10.1016\/j.jbc.2021.100283_bib15","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2015.447","article-title":"Glutaminolysis as a target for cancer therapy","volume":"35","author":"Jin","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2021.100283_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12943-016-0555-x","article-title":"Cancer stem cell metabolism: A potential target for cancer therapy","volume":"15","author":"Deshmukh","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2021.100283_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fendo.2017.00150","article-title":"Is There a therapeutic window for metabolism-based cancer therapies?","volume":"8","author":"Fendt","year":"2017","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jbc.2021.100283_bib18","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1074\/jbc.M117.782052","article-title":"Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma","volume":"292","author":"Dolezal","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100283_bib19","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1158\/0008-5472.CAN-17-1325","article-title":"Genetic Dissociation of glycolysis and the TCA cycle affects Neither normal nor neoplastic proliferation","volume":"77","author":"Jackson","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2021.100283_bib20","doi-asserted-by":"crossref","first-page":"26241","DOI":"10.1074\/jbc.M116.754218","article-title":"Coordinated activities of multiple myc-dependent and myc-independent biosynthetic pathways in hepatoblastoma","volume":"291","author":"Wang","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100283_bib21","doi-asserted-by":"crossref","first-page":"14740","DOI":"10.1074\/jbc.RA118.004099","article-title":"Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice","volume":"293","author":"Wang","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100283_bib22","doi-asserted-by":"crossref","first-page":"17524","DOI":"10.1074\/jbc.RA119.009979","article-title":"beta-Catenin mutations as determinants of hepatoblastoma phenotypes in mice","volume":"294","author":"Zhang","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100283_bib23","doi-asserted-by":"crossref","first-page":"13050","DOI":"10.1021\/jf203182d","article-title":"Variability in coconut (Cocos nucifera L.) germplasm and hybrids for fatty acid profile of oil","volume":"59","author":"Kumar","year":"2011","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.jbc.2021.100283_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.nutr.21.1.193","article-title":"Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: An adaptive metabolic system","volume":"21","author":"Reddy","year":"2001","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.jbc.2021.100283_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2013.08.032","article-title":"The peroxisomal enzyme L-PBE is required to prevent the dietary toxicity of medium-chain fatty acids","volume":"5","author":"Ding","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2021.100283_bib26","doi-asserted-by":"crossref","first-page":"15775","DOI":"10.1074\/jbc.274.22.15775","article-title":"Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase\/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism","volume":"274","author":"Qi","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100283_bib27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","article-title":"Activation of beta-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice","volume":"147","author":"Tao","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbc.2021.100283_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3727\/105221616X693639","article-title":"Novel Advances in Understanding of molecular Pathogenesis of hepatoblastoma: A Wnt\/beta-catenin Perspective","volume":"17","author":"Bell","year":"2017","journal-title":"Gene Expr."},{"key":"10.1016\/j.jbc.2021.100283_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","article-title":"Hepatoblastoma state of the art: Pathology, genetics, risk stratification, and chemotherapy","volume":"26","author":"Czauderna","year":"2014","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.jbc.2021.100283_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.semdp.2016.12.015","article-title":"Hepatoblastoma","volume":"34","author":"Sharma","year":"2017","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.jbc.2021.100283_bib31","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/ijms18061126","article-title":"The peroxisome-mitochondria Connection: How and Why?","volume":"18","author":"Fransen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2021.100283_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hep.29672","article-title":"New insights into diagnosis and therapeutic options for proliferative hepatoblastoma","volume":"68","author":"Hooks","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2021.100283_bib33","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nature03043","article-title":"MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer","volume":"431","author":"Shachaf","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.100283_bib34","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.bcp.2008.03.004","article-title":"Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases","volume":"75","author":"Hardwick","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2021.100283_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12885-020-06756-x","article-title":"Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers","volume":"20","author":"Mandel","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2021.100283_bib36","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12885-019-5851-6","article-title":"Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancers","volume":"19","author":"Mandel","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2021.100283_bib37","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1152\/ajpendo.00093.2009","article-title":"The Randle cycle revisited: A\u00a0new\u00a0head for an old hat","volume":"297","author":"Hue","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2021.100283_bib38","doi-asserted-by":"crossref","first-page":"e0218186","DOI":"10.1371\/journal.pone.0218186","article-title":"Inhibition of hepatocellular carcinoma by metabolic normalization","volume":"14","author":"Wang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.100283_bib39","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-15-0876","article-title":"Plasminogen activator inhibitor-1 in cancer: Rationale and insight for Future therapeutic testing","volume":"75","author":"Placencio","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2021.100283_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature22379","article-title":"Nutrient acquisition strategies of mammalian cells","volume":"546","author":"Palm","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.100283_bib41","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jbc.2021.100283_bib42","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","article-title":"Metabolic regulation of cell growth and proliferation","volume":"20","author":"Zhu","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2021.100283_bib43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-3-319-42118-6_12","article-title":"Fasting and caloric restriction in cancer Prevention and treatment","volume":"207","author":"Brandhorst","year":"2016","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.jbc.2021.100283_bib44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.aau2095","article-title":"A\u00a0time to fast","volume":"362","author":"Di Francesco","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jbc.2021.100283_bib45","doi-asserted-by":"crossref","first-page":"124ra127","DOI":"10.1126\/scitranslmed.3003293","article-title":"Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy","volume":"4","author":"Lee","year":"2012","journal-title":"Sci. Transl Med."},{"key":"10.1016\/j.jbc.2021.100283_bib46","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41568-018-0061-0","article-title":"Fasting and cancer: Molecular mechanisms and clinical application","volume":"18","author":"Nencioni","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2021.100283_bib47","doi-asserted-by":"crossref","first-page":"e27713","DOI":"10.7554\/eLife.27713","article-title":"Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition","volume":"6","author":"Muir","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2021.100283_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10409238.2019.1611733","article-title":"Determinants of nutrient limitation in cancer","volume":"54","author":"Sullivan","year":"2019","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.jbc.2021.100283_bib49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-cancerbio-030617-050329","article-title":"Nutrient sensing in cancer","volume":"2","author":"Torrence","year":"2018","journal-title":"Annu. Rev. Canc Biol."},{"key":"10.1016\/j.jbc.2021.100283_bib50","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1158\/0008-5472.CAN-05-4673","article-title":"Fatty acid synthase and cancer: New application of an old pathway","volume":"66","author":"Kuhajda","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2021.100283_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccell.2018.04.011","article-title":"Biological role and therapeutic potential of IDH mutations in cancer","volume":"34","author":"Waitkus","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2021.100283_bib52","doi-asserted-by":"crossref","first-page":"13464","DOI":"10.1074\/jbc.RA119.008743","article-title":"De novo synthesis of serine and glycine fuels purine nucleotide biosynthesis in human lung cancer tissues","volume":"294","author":"Fan","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100283_bib53","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2217\/fon-2017-0523","article-title":"The role of IDH mutations in acute myeloid leukemia","volume":"14","author":"Montalban-Bravo","year":"2018","journal-title":"Future Oncol."},{"key":"10.1016\/j.jbc.2021.100283_bib54","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML","volume":"378","author":"DiNardo","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2021.100283_bib55","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1158\/1078-0432.CCR-18-3749","article-title":"FDA approval summary: Ivosidenib for Relapsed or Refractory acute myeloid leukemia with an isocitrate dehydrogenase-1 Mutation","volume":"25","author":"Norsworthy","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2021.100283_bib56","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbabio.2017.01.012","article-title":"Mitochondria and cancer chemoresistance","volume":"1858","author":"Guerra","year":"2017","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.jbc.2021.100283_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-319-55780-9_2","article-title":"Biochemical and clinical Aspects of hereditary tyrosinemia type 1","volume":"959","author":"Morrow","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jbc.2021.100283_bib58","doi-asserted-by":"crossref","first-page":"e0193477","DOI":"10.1371\/journal.pone.0193477","article-title":"The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma","volume":"13","author":"Ambrosetti","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.100283_bib59","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1158\/0008-5472.CAN-14-0254","article-title":"Metabolic vulnerabilities in endometrial cancer","volume":"74","author":"Byrne","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2021.100283_bib60","doi-asserted-by":"crossref","first-page":"13537","DOI":"10.1073\/pnas.2233850100","article-title":"Protein profiles associated with survival in lung adenocarcinoma","volume":"100","author":"Chen","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.100283_bib61","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s13139-018-0555-4","article-title":"Predictive value of preoperative Volume-based 18F-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography\/Computed Tomography Parameters in patients with Resectable lung adenocarcinoma","volume":"52","author":"Choi","year":"2018","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jbc.2021.100283_bib62","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.3802\/jgo.2016.27.e15","article-title":"Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer","volume":"27","author":"Chung","year":"2016","journal-title":"J.\u00a0Gynecol. Oncol."},{"key":"10.1016\/j.jbc.2021.100283_bib63","doi-asserted-by":"crossref","first-page":"13371","DOI":"10.18632\/oncotarget.3823","article-title":"Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma","volume":"6","author":"Lucarelli","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2021.100283_bib64","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/JTO.0000000000000286","article-title":"Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma","volume":"9","author":"Schuurbiers","year":"2014","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.jbc.2021.100283_bib65","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.redox.2014.08.002","article-title":"Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism","volume":"2","author":"Allen","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.jbc.2021.100283_bib66","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1158\/0008-5472.CAN-09-3228","article-title":"Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index","volume":"70","author":"Lee","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2021.100283_bib67","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.matbio.2017.09.001","article-title":"Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior","volume":"65","author":"Bandari","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jbc.2021.100283_bib68","first-page":"1387","article-title":"Extracellular matrix as target for antitumor therapy","volume":"8","author":"Harisi","year":"2015","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.jbc.2021.100283_bib69","doi-asserted-by":"crossref","first-page":"a026781","DOI":"10.1101\/cshperspect.a026781","article-title":"Tumor Microenvironment and differential responses to therapy","volume":"7","author":"Hirata","year":"2017","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"10.1016\/j.jbc.2021.100283_bib70","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.addr.2015.10.007","article-title":"In\u00a0vitro cancer cell-ECM interactions inform in\u00a0vivo cancer treatment","volume":"97","author":"Holle","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jbc.2021.100283_bib71","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","article-title":"Intratumor heterogeneity: The Rosetta Stone of therapy resistance","volume":"37","author":"Marusyk","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2021.100283_bib72","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc2714","article-title":"Environment-mediated drug resistance: A major contributor to minimal residual disease","volume":"9","author":"Meads","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2021.100283_bib73","doi-asserted-by":"crossref","first-page":"e0182705","DOI":"10.1371\/journal.pone.0182705","article-title":"Ribosomopathy-like properties of murine and human cancers","volume":"12","author":"Kulkarni","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.100283_bib74","doi-asserted-by":"crossref","first-page":"30379","DOI":"10.18632\/oncotarget.8856","article-title":"Abnormal lipid processing but normal long-term repopulation potential of myc-\/- hepatocytes","volume":"7","author":"Edmunds","year":"2016","journal-title":"Oncotarget"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582100051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582100051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T03:07:34Z","timestamp":1634440054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582100051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":74,"alternative-id":["S002192582100051X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100283","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired deficiency of peroxisomal dicarboxylic acid catabolism is a metabolic vulnerability in hepatoblastoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100283"}}